Obalon Announces First Commercial Shipment of its Navigation Balloon Placement System with Touch Inflation Dispenser
22 févr. 2019 08h25 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Fourth Quarter and Full Year 2018 Financial Results
22 févr. 2019 08h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Fourth Quarter and Year End 2018 Financial Results Conference Call for February 22, 2019 at 8:30 a.m. Eastern Time
15 févr. 2019 09h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Promotion of Amy VandenBerg to Chief Clinical & Regulatory Affairs Officer
03 janv. 2019 08h15 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon to Host Call to Provide Update on Commercial Strategy Post FDA Approval of the Obalon Navigation System
02 janv. 2019 09h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Promotion of Kelly Huang, Ph.D. To Chief Executive Officer
02 janv. 2019 08h45 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital
27 déc. 2018 17h53 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces FDA Approval of Obalon Navigation System
21 déc. 2018 09h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Key Weight Loss and Safety Data Presented for the Obalon Swallowable Gas-Filled Balloon System at the 35th ASMBS Annual Meeting at Obesity Week 2018
15 nov. 2018 09h15 HE
|
Obalon Therapeutics, Inc.
Clinical results presented from over 1,300 patients treated at 108 sites with Obalon’s non-surgical weight loss solution in commercial setting SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Obalon...
Obalon Balloon System Data to be Featured in Presentation During 35th ASMBS Annual Meeting at Obesity Week 2018
07 nov. 2018 09h15 HE
|
Obalon Therapeutics, Inc.
Clinical results from over 1,300 patients at 108 sites treated with Obalon’s novel weight loss device solution in commercial use SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics,...